Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06143553 | Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer | unknown | Phase 3 | 168 | Shanghai Yizhong Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 29, 2024 | clinicaltrials |
| NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) | unknown | Phase 3 | 271 | Prof. Wolfgang JanniOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT02441933 |
| Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial) |
| unknown |
| Phase 3 |
| 878 |
| Yonsei UniversityOTHER |
| 1 |
| Jun 4, 2024 |
| clinicaltrials |
| NCT01064635 | Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)(GIM4) | unknown | Phase 3 | 2,056 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT00382070 | Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer | unknown | Phase 3 | 3,966 | NSABP Foundation IncNETWORK | 3 | Mar 22, 2024 | clinicaltrials |
| NCT03423199 | PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY(PATHWAY) | unknown | Phase 3 | 180 | National Cancer Center, JapanOTHER_GOV | 4 | Mar 22, 2024 | clinicaltrials |
| NCT05861830 | Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) | unknown | Phase 3 | 80 | Peking Union Medical College HospitalOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT03500380 | A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases | unknown | Phase 2 / Phase 3 | 301 | RemeGen Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05954442 | Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype(BCTOP-T-M03) | unknown | Phase 3 | 203 | Fudan UniversityOTHER | 1 | Jan 16, 2024 | clinicaltrials |
| NCT05523609 | Vitamin D and Calcium Supplementation in Breast Cancer | unknown | Phase 2 / Phase 3 | 40 | Tanta UniversityOTHER | 1 | Dec 1, 2023 | clinicaltrials |
| NCT06152471 | Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer(ASF-BC) | unknown | Phase 3 | 100 | Henrik LindmanOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT03926091 | Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer(CLOVER) | unknown | Phase 3 | 2,172 | Fudan UniversityOTHER | 1 | Nov 14, 2023 | clinicaltrials |
| NCT05673629 | Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer | unknown | Phase 3 | 552 | Beijing Biostar Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Nov 8, 2023 | clinicaltrials |
| NCT05144867 | Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis(SRSvsWBRT) | unknown | Phase 3 | 98 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05755048 | FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 3 | 314 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY | 1 | Sep 1, 2023 | clinicaltrials |
| NCT05985187 | Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer. | unknown | Phase 3 | 412 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05433480 | A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer | unknown | Phase 3 | 274 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT01579734 | Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users(HOT) | unknown | Phase 3 | 1,884 | European Institute of OncologyOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT05790096 | Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy | unknown | Phase 3 | 60 | Blau Farmaceutica S.A.INDUSTRY | 0 | Mar 29, 2023 | clinicaltrials |
| NCT00412022 | HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.(HOBOE) | unknown | Phase 3 | 1,294 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT04924699 | A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer | unknown | Phase 2 / Phase 3 | 350 | Shanghai Miracogen Inc.INDUSTRY | 1 | Mar 17, 2023 | clinicaltrials |
| NCT05753865 | A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound) | unknown | Phase 3 | 454 | CSPC Ouyi Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05728632 | Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines(CONTROL) | unknown | Phase 3 | 80 | Giulio StefaniniOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05720026 | Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer | unknown | Phase 3 | 560 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Feb 9, 2023 | clinicaltrials |
| NCT02914158 | Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women(ASPAIT) | unknown | Phase 3 | 680 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05670054 | Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients | unknown | Phase 3 | 116 | Mansoura UniversityOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT03863223 | A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer | unknown | Phase 3 | 590 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Nov 23, 2022 | clinicaltrials |
| NCT00887380 | STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)(STARS) | unknown | Phase 3 | 2,023 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Nov 18, 2022 | clinicaltrials |
| NCT05103644 | Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients" | unknown | Phase 2 / Phase 3 | 60 | Beni-Suef UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05595109 | Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients | unknown | Phase 2 / Phase 3 | 56 | Tanta UniversityOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05518292 | Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery | unknown | Phase 2 / Phase 3 | 60 | Mansoura UniversityOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT04429893 | Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy | unknown | Phase 2 / Phase 3 | 80 | Alexandria UniversityOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT02786875 | Diet, Exercise and Vitamin D in Breast Cancer Recurrence(DEDiCa) | unknown | Phase 3 | 506 | National Cancer Institute, NaplesOTHER | 1 | May 23, 2022 | clinicaltrials |
| NCT02062489 | Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients | unknown | Phase 3 | 688 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 27, 2022 | clinicaltrials |
| NCT05346861 | Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab | unknown | Phase 3 | 240 | Fudan UniversityOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT04918589 | Tranexamic Acid for Alloplastic Breast Reconstruction | unknown | Phase 3 | 106 | McMaster UniversityOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT05253066 | Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer | unknown | Phase 2 / Phase 3 | 130 | Shengjing HospitalOTHER | 0 | Feb 23, 2022 | clinicaltrials |
| NCT02236806 | Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab(SAFE) | unknown | Phase 3 | 262 | Azienda Ospedaliero-Universitaria CareggiOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT00212121 | Radiation Dose Intensity Study in Breast Cancer in Young Women | unknown | Phase 3 | 2,400 | The Netherlands Cancer InstituteOTHER | 2 | Jan 21, 2022 | clinicaltrials |
| NCT05189067 | Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer | unknown | Phase 2 / Phase 3 | 190 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 12, 2022 | clinicaltrials |
| NCT04646564 | Radiotherapy for Extracranial Oligometastatic Breast Cancer | unknown | Phase 3 | 170 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05164952 | Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole | unknown | Phase 3 | 50 | Assiut UniversityOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT04612439 | Accuracy of VABB Elite 10G Versus BARD 14G CNB | unknown | Phase 3 | 1,470 | Fudan UniversityOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT04047758 | Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer | unknown | Phase 3 | 420 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03538171 | Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer | unknown | Phase 3 | 375 | Taizhou EOC Pharma Co., Ltd.INDUSTRY | 1 | Jul 9, 2021 | clinicaltrials |
| NCT03580395 | Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer | unknown | Phase 2 / Phase 3 | 200 | Hebei Medical University Fourth HospitalOTHER | 1 | Jul 9, 2021 | clinicaltrials |
| NCT03927456 | A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer | unknown | Phase 3 | 357 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 3, 2021 | clinicaltrials |
| NCT03966898 | A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer | unknown | Phase 3 | 426 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 2, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Nov 29, 2024source: clinicaltrials